Showing results (151-160 of 250) with videos related to
Sort By:
Pageof 25
American Journal of Clinical Oncology|February 1, 1983
Combination chemotherapy for advanced sarcomas of bone and mesothelioma utilizing rubidazone and DTIC: a Southwest Oncology Group StudyB L Zidar, R S Benjamin, J Frank, et al.Obstetrics and Gynecology|August 1, 1978
Mitomycin C, vincristine, and bleomycin therapy for advanced cervical cancerL H Baker, M I Opipari, H Wilson, et al.Oncology|August 7, 1999
Fluoropyrimidines: a critical evaluationR A Brito, D Medgyesy, T H Zukowski, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2005
The advisory process for anticancer drug regulation: a global perspectiveA T Farrell, I Papadouli, A Hori, et al.Cancer Treatment Reports|September 1, 1979
Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group StudyM K Samson, R L Stephens, S Rivkin, et al.Investigational New Drugs|November 1, 1991
Phase II study of amonafide in advanced pancreatic adenocarcinomaK Linke, R Pazdur, J L Abbruzzese, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study GroupD Cunningham, J Zalcberg, I Smith, et al.Journal of Biological Response Modifiers|October 1, 1990
A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicityJ L Abbruzzese, B Levin, J A Ajani, et al.American Journal of Clinical Oncology|February 20, 1999
Phase II trial of docetaxel for cholangiocarcinomaR Pazdur, M E Royce, G I Rodriguez, et al.Cancer Research|July 1, 1980
Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusionR J Fraile, L H Baker, T R Buroker, et al.Pageof 25